Jolkinolide B

• CAT Number: R072570
• CAS Number: 37905-08-1
• PubChem Substance ID: 161954
• Molecular Formula: C20H26O4
• Molecular Weight: 330.42
• Purity: ≥95%
• Target: Apoptosis
• IUPAC Name: (1S,3R,8R,10R,11R,12R,17R)-5,12,16,16-tetramethyl-2,7,9-trioxahexacyclo[9.8.0.01,3.04,8.08,10.012,17]nonadec-4-en-6-one
• InChI: InChI=1S/C20H26O4/c1-10-12-14-19(22-14)9-6-11-17(2,3)7-5-8-18(11,4)13(19)15-20(12,23-15)24-16(10)21/h11,13-15H,5-9H2,1-4H3/t11-,13+,14-,15-,18-,19+,20-/m1/s1
• InChIKey: SOVOCMGDFRGRKF-MCDHERAVSA-N
• SMILES: CC1=C2C3C4(O3)CCC5C(CCCC5(C4C6C2(O6)OC1=O)C)(C)C

Jolkinolide B（Cat No.:R072570）, is a naturally occurring diterpenoid found in the plant Euphorbia fischeriana Steud. It exhibits various pharmacological activities, including anti-inflammatory, immunomodulatory, and anticancer effects. Jolkinolide B has shown potential as an anti-inflammatory agent by inhibiting the production of pro-inflammatory mediators. It is being studied for its therapeutic applications in the treatment of inflammatory diseases, autoimmune disorders, and certain types of cancer. However, further research is needed to fully understand its mechanisms of action, safety, and optimal uses in medicine.